Alexander A. Seelenberger - Nov 15, 2022 Form 4 Insider Report for Vincerx Pharma, Inc. (VINC)

Role
Chief Financial Officer
Signature
By: /s/ Alexander A. Seelenberger
Stock symbol
VINC
Transactions as of
Nov 15, 2022
Transactions value $
$0
Form type
4
Date filed
11/17/2022, 03:05 PM
Previous filing
Aug 29, 2022
Next filing
Feb 16, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VINC Stock Option (right to buy) Award $0 +56K $0.00 56K Nov 15, 2022 Common Stock 56K $0.82 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option vests in twenty-four equal monthly installments starting from November 15, 2022.

Remarks:

Represents the 2nd tranche of stock option grants previously approved by the Compensation Committee on August 25, 2022.